Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
Conditions: HIV Infections; Staphylococcal InfectionsInterventions: Drug: Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%; Drug: PlaceboSponsors: Uniformed Services University of the Health Sciences; Infectious Diseases Clinical Research Program; National Institute of Allergy and Infectious Diseases (NIAID); US Military HIV Research ProgramActive, not recruiting - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Health | Infectious Diseases | MRSA | Mupirocin | Research | Staphylococcus Aureus | Study | Superbugs